Is cannabis safe after 65? Stanford experts reveal 5 risks older adults should know
Cannabis use among older adults is rising fast, but today’s marijuana is far more potent than many people realize — and experts warn the risks may be underestimated. Stanford Medicine specialists say modern cannabis can increase the chances of heart problems, falls, memory issues, dangerous drug interactions, and even addiction, especially for people over 65.
External link. We are not responsible for the content.
Read more ↗More From ScienceDaily Psychedelics
Scientists say just 7 days of meditation can rewire your brain
An intensive seven-day meditation retreat triggered striking changes across the brain and body, including shifts tied...
Magic mushrooms may reshape the brain long after the trip ends
A single dose of psilocybin produced measurable changes in brain activity and possible changes in brain structure tha...
New psychedelic-like drugs could treat depression without making you trip
UC Davis researchers created brand-new psychedelic-like compounds by shining UV light on amino acid-based molecules. ...
Latest News
Why Most Drugs Fail, and Why Virtual Tissue Models Beat Virtual Cell Models
Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness!
Ibogaine’s Momentum Is Real. So Is the Safety Gap Nobody’s Solving.
Recent reporting, has documented a string of serious adverse events at overseas psychedelic clinics such as cardiac d...
Was Carlos Castaneda Among the First Psychedelic Grifters?
Author Carlos Castaneda built a fortune on a fabricated Indigenous lineage. A new biography shows how his blueprint s...
University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...
Who Gets to Heal?
A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether...
Weekly Psychedelic Policy Briefing: August 23, 2026
Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increa...